论文部分内容阅读
摘要我们反对动脉注射碘基对比剂(CM)引起对比剂性肾病(CIN)的危险大于静脉注射的观点,因为:①在经动脉冠状动脉介入及大多数其他经动脉血管造影检查中,相对于肾脏CM也是经静脉注射的;②缺乏在危险因素及CM剂量匹配下动脉内与静脉内注射的对照性研究;③危险因素较少病人的
Abstract We are opposed to the idea that the risk of contrast-induced nephropathy (CIN) caused by arterial injection of iodine-based contrast agent (CM) is greater than that of intravenous injection because: ① in the measurement of arterial coronary artery disease and in most other arterial angiographic studies, Kidney CM is also intravenous injection; ② the lack of risk factors and CM dose matching arterial and intravenous injection of control studies; ③ less risk factors in patients